Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 996-999, August 1995

Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: Evidence for increased oxidative stress as a variable complication

  • John Cunninghamn

      Affiliations

    • Corresponding Author InformationAddress reprint requests to John Cunningham, PhD, Department of Nutrition, Chenoweth Lab, Box 31420, University of Massachusetts, Amherst, MA 01003-1420.
    • Department of Nutrition, University of Massachusetts, Amherst, USA
    • Shriners Burns Institute, Boston, MA, USA
    • Children's Hospital Oakland Research Institute, Oakland, CA, USA
  • ,
  • Marlene Leffell

      Affiliations

    • Department of Nutrition, University of Massachusetts, Amherst, USA
    • Shriners Burns Institute, Boston, MA, USA
    • Children's Hospital Oakland Research Institute, Oakland, CA, USA
  • ,
  • Patricia Mearkle

      Affiliations

    • Department of Nutrition, University of Massachusetts, Amherst, USA
    • Shriners Burns Institute, Boston, MA, USA
    • Children's Hospital Oakland Research Institute, Oakland, CA, USA
  • ,
  • Paul Harmatz

      Affiliations

    • Department of Nutrition, University of Massachusetts, Amherst, USA
    • Shriners Burns Institute, Boston, MA, USA
    • Children's Hospital Oakland Research Institute, Oakland, CA, USA

Received 11 June 1994; accepted 5 December 1994.

Abstract 

Cerulopiasmin (Cp) is an acute-phase—responsive oxidase enzyme. Prior reports suggest that Cp is increased in diabetes mellitus, perhaps reflecting greater oxidant stress. However, the situation in insulin-dependent diabetes mellitus (IDDM) per se remains unclear. Furthermore, vitamin C can interfere with one indirect assay for Cp, and vitamin C metabolism is altered in IDDM. We measured Cp levels by both a direct radial immunodiffusion (RID) assay and an indirect oxidase assay in 10 subjects with IDDM and 10 nondiabetics, both at baseline and after 30 days of vitamin C supplementation (100 or 600 mg daily, five subjects per group). Plasma copper level was measured independently also. Our data show that circulating levels of Cp are significantly increased in IDDM subjects as a group, and specifically that Cp is abnormally high in a subset of IDDM individuals. Vitamin C supplementation at either dose interfered with the oxidase assay for Cp in both groups, but vitamin C did not alter the RID assay. The observed increase in plasma copper suggests that circulating holo-Cp is increased. The finding of increased Cp in some individuals with IDDM supports the hypothesis of increased oxidant stress as a variable factor in the spectrum of chronic complications in diabetes. Measurements of Cp level by the oxidase assay must be considered unreliable for subjects taking vitamin C supplements of ≥100 mg/d.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by funds from the Shriners Hospitals for Crippled Children (project no. 15851) and Hoffrnann-LaRoche.

PII: 0026-0495(95)90095-0

Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 996-999, August 1995